Meritage Homes
MTH
KB Home
KBH
D.R. Horton
DHI
4
Adobe
ADBE
5
Lennar Corp
LEN
US Stock MarketDetailed Quotes
NRSN NeuroSense Therapeutics
- 0.9800
- +0.0100+1.03%
Close Apr 30 16:00 ET
- 0.9800
- 0.00000.00%
Post 16:04 ET
23.51MMarket Cap-1.81P/E (TTM)
1.0000High0.9500Low53.69KVolume0.9600Open0.9700Pre Close52.16KTurnover0.45%Turnover RatioLossP/E (Static)23.99MShares1.500052wk High9.07P/B11.69MFloat Cap0.512052wk Low--Dividend TTM11.93MShs Float8.1800Historical High--Div YieldTTM5.16%Amplitude0.4000Historical Low0.9710Avg Price1Lot Size
NeuroSense Therapeutics Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | -17.82%9.9M | -42.16%1.77M | -19.76%2.11M | -10.09%3.03M | 0.10%2.99M | 14.17%12.05M | 703.67%3.06M | -20.88%2.63M | -6.13%3.37M | -8.36%2.99M |
| Selling and administrative expenses | -11.96%4.2M | -40.74%685K | -11.42%946K | 3.47%1.46M | -2.37%1.11M | -3.87%4.78M | 446.11%1.16M | -33.79%1.07M | -17.91%1.41M | -42.12%1.14M |
| -General and administrative expense | -11.96%4.2M | -40.74%685K | -11.42%946K | 3.47%1.46M | -2.37%1.11M | -3.87%4.78M | 446.11%1.16M | -33.79%1.07M | -17.91%1.41M | -42.12%1.14M |
| Research and development costs | -21.67%5.7M | -43.02%1.09M | -25.48%1.16M | -19.87%1.57M | 1.62%1.88M | 30.20%7.27M | 166.57%1.91M | -8.68%1.56M | 4.71%1.96M | 42.90%1.85M |
| Operating profit | 17.82%-9.9M | 42.16%-1.77M | 19.76%-2.11M | 10.09%-3.03M | -0.10%-2.99M | -14.17%-12.05M | -703.67%-3.06M | 20.88%-2.63M | 6.13%-3.37M | 8.36%-2.99M |
| Net non-operating interest income expense | -14.44%-309K | 98.67%-31K | -101.80%-41K | 887.32%2.17M | -3,697.01%-2.41M | -421.43%-270K | -159.96%-2.34M | 135.12%2.28M | 48.31%-276K | -87.80%67K |
| Non-operating interest income | -98.88%2K | ---- | ---- | ---- | ---- | 95.60%178K | ---- | ---- | ---- | -88.29%67K |
| Non-operating interest expense | ---- | ---- | ---- | ---2.17M | --2.41M | ---- | ---- | ---- | ---- | ---- |
| Total other finance cost | -30.58%311K | -98.69%33K | ---- | ---- | ---- | 6,300.00%448K | --2.52M | ---- | ---- | ---- |
| Other net income (expense) | -99.95%1K | 10,154.55%2.21M | ||||||||
| Gain on sale of security | -99.95%1K | ---- | ---- | ---- | ---- | 10,154.55%2.21M | ---- | ---- | ---- | ---- |
| Income before tax | -1.02%-10.21M | 43.49%-1.8M | -513.71%-2.15M | 76.49%-857K | -84.82%-5.4M | 3.67%-10.11M | -144.78%-3.19M | 88.31%-350K | -4.74%-3.65M | -7.70%-2.92M |
| Income tax | ||||||||||
| Net income | -1.02%-10.21M | 43.49%-1.8M | -513.71%-2.15M | 76.49%-857K | -84.82%-5.4M | 3.67%-10.11M | -144.78%-3.19M | 88.31%-350K | -4.74%-3.65M | -7.70%-2.92M |
| Net income continuous Operations | -1.02%-10.21M | 43.49%-1.8M | -513.71%-2.15M | 76.49%-857K | -84.82%-5.4M | 3.67%-10.11M | -144.78%-3.19M | 88.31%-350K | -4.74%-3.65M | -7.70%-2.92M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | -1.02%-10.21M | 43.49%-1.8M | -513.71%-2.15M | 76.49%-857K | -84.82%-5.4M | 3.67%-10.11M | -144.78%-3.19M | 88.31%-350K | -4.74%-3.65M | -7.70%-2.92M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | -1.02%-10.21M | 43.49%-1.8M | -513.71%-2.15M | 76.49%-857K | -84.82%-5.4M | 3.67%-10.11M | -144.78%-3.19M | 88.31%-350K | -4.74%-3.65M | -7.70%-2.92M |
| Basic earnings per share | 27.03%-0.54 | 68.42%-0.06 | -0.11 | 93.33%-0.02 | -40.00%-0.35 | 18.68%-0.74 | -72.73%-0.19 | 0 | 3.23%-0.3 | -4.17%-0.25 |
| Diluted earnings per share | 27.03%-0.54 | 68.42%-0.06 | -0.11 | 93.33%-0.02 | -40.00%-0.35 | 18.68%-0.74 | -72.73%-0.19 | 0 | 3.23%-0.3 | -4.17%-0.25 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- |
Market Insights
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
Discussing
Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks
Moo Earnings
Feb 17 19:21
Alibaba Q4 FY2024 Earnings Preview: Predict & Win Big! 🚀